20042103|t|Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders.
20042103|a|Polyunsaturated fatty acids (PUFAs) form an important constituent of all the cell membranes in the body. PUFAs such as arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) form precursors to both pro-inflammatory and anti-inflammatory compounds. Low-grade systemic inflammation occurs in clinical conditions such as insulin resistance, hypertension, type 2 diabetes mellitus, atherosclerosis, coronary heart disease, lupus, schizophrenia, Alzheimer's disease, and other dementias, cancer and non-alcoholic fatty liver disease (NAFLD) that are also characterized by an alteration in the metabolism of essential fatty acids in the form of excess production of pro-inflammatory eicosanoids and possibly, decreased synthesis and release of anti-inflammatory lipoxins, resolvins, protectins and maresins. We propose that low-grade systemic inflammation observed in these clinical conditions is due to an imbalance in the metabolism of essential fatty acids that is more in favour of pro-inflammatory molecules. In this context, transgenic fat-1 mouse that is designed to convert n-6 to n-3 fatty acids could form an ideal model to study the altered metabolism of essential fatty acids in the above mentioned conditions. It is envisaged that low-grade systemic inflammatory conditions are much less likely in the fat-1 mouse and/or these diseases will run a relatively mild course. Identifying the anti-inflammatory compounds from n-3 fatty acids that suppress low-grade systemic inflammatory conditions and understanding their mechanism(s) of action may lead to newer therapeutic strategies.
20042103	14	16	-1	CellLine	CVCL:C7RB
20042103	17	22	mouse	Species	10090
20042103	66	120	cardiovascular, neurological and psychiatric disorders	Disease	MESH:D001523
20042103	122	149	Polyunsaturated fatty acids	Chemical	MESH:D005231
20042103	151	156	PUFAs	Chemical	MESH:D005231
20042103	227	232	PUFAs	Chemical	MESH:D005231
20042103	241	257	arachidonic acid	Chemical	MESH:D016718
20042103	264	285	eicosapentaenoic acid	Chemical	MESH:D015118
20042103	287	290	EPA	Chemical	MESH:D015118
20042103	296	316	docosahexaenoic acid	Chemical	MESH:D004281
20042103	318	321	DHA	Chemical	MESH:D004281
20042103	351	363	inflammatory	Disease	MESH:D007249
20042103	373	385	inflammatory	Disease	MESH:D007249
20042103	407	415	systemic	Disease	MESH:D015619
20042103	416	428	inflammation	Disease	MESH:D007249
20042103	467	485	insulin resistance	Disease	MESH:D007333
20042103	487	499	hypertension	Disease	MESH:D006973
20042103	501	525	type 2 diabetes mellitus	Disease	MESH:D003924
20042103	527	542	atherosclerosis	Disease	MESH:D050197
20042103	544	566	coronary heart disease	Disease	MESH:D003327
20042103	568	573	lupus	Disease	MESH:D008180
20042103	575	588	schizophrenia	Disease	MESH:D012559
20042103	590	609	Alzheimer's disease	Disease	MESH:D000544
20042103	621	630	dementias	Disease	MESH:D003704
20042103	632	638	cancer	Disease	MESH:D009369
20042103	643	676	non-alcoholic fatty liver disease	Disease	MESH:D065626
20042103	678	683	NAFLD	Disease	MESH:D065626
20042103	751	772	essential fatty acids	Chemical	MESH:D005228
20042103	813	825	inflammatory	Disease	MESH:D007249
20042103	826	837	eicosanoids	Chemical	MESH:D015777
20042103	892	904	inflammatory	Disease	MESH:D007249
20042103	905	913	lipoxins	Chemical	MESH:D044045
20042103	915	924	resolvins	Chemical	-
20042103	941	949	maresins	Chemical	-
20042103	977	985	systemic	Disease	MESH:D015619
20042103	986	998	inflammation	Disease	MESH:D007249
20042103	1081	1102	essential fatty acids	Chemical	MESH:D005228
20042103	1133	1145	inflammatory	Disease	MESH:D007249
20042103	1188	1190	-1	CellLine	CVCL:C7RB
20042103	1191	1196	mouse	Species	10090
20042103	1225	1228	n-6	Chemical	-
20042103	1232	1247	n-3 fatty acids	Chemical	MESH:D015525
20042103	1309	1330	essential fatty acids	Chemical	MESH:D005228
20042103	1397	1405	systemic	Disease	MESH:D015619
20042103	1406	1429	inflammatory conditions	Disease	MESH:D007249
20042103	1464	1469	mouse	Species	10090
20042103	1548	1560	inflammatory	Disease	MESH:D007249
20042103	1576	1591	n-3 fatty acids	Chemical	MESH:D015525
20042103	1616	1624	systemic	Disease	MESH:D015619
20042103	1625	1648	inflammatory conditions	Disease	MESH:D007249
20042103	Association	MESH:D005228	MESH:D009369
20042103	Positive_Correlation	MESH:D015777	MESH:D007249
20042103	Positive_Correlation	MESH:D015777	MESH:D065626
20042103	Negative_Correlation	MESH:D015525	MESH:D007249
20042103	Association	MESH:D005228	MESH:D003704
20042103	Association	MESH:D005228	MESH:D007249
20042103	Positive_Correlation	MESH:D015777	MESH:D015619
20042103	Negative_Correlation	MESH:D015525	MESH:D015619
20042103	Association	MESH:D005228	MESH:D015777
20042103	Negative_Correlation	MESH:D004281	MESH:D007249
20042103	Association	MESH:D005228	MESH:D065626
20042103	Negative_Correlation	MESH:D015118	MESH:D007249
20042103	Negative_Correlation	MESH:D044045	MESH:D007249
20042103	Association	MESH:D005228	MESH:D015619

